Karen Reddin

Dr Karen Reddin

  • Senior Lecturer in Immersive Environments for Disaster
Back to top

Research

Disaster Preparedness and Response Capacity Assessment in the Eastern Caribbean.

Journal Articles

  • Reddin, K., 2018. The Promotion of Grab Bags as Disaster Risk Reduction Strategy. PLOS Currents Disasters.
  • Reddin, K., Lee, H. and Boulton, I., 2007. Neisserial Outer Membrane Vesicles Bind the Coinhibitory Receptor Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 and Suppress CD4+. Infection and immunity, 75 (9), 4449-4455.
  • Reddin, K., Mukhopadhyay, T., Halliwell, D., O'Dwyer, C. and Gorringe, A., 2005. Rapid Characterisation of Outer Membrane Proteins in Neisseria lactamica by Surface Enhanced Laser Desorption and Ionisation – Time Of Flight Mass Spectroscopy for use in a meningococcal vaccine. Biotechnology and Applied Biochemistry, 41 (2), 175-182.
  • Reddin, K., O'Dwyer, C. and Gorringe, A., 2004. Expression of Heterologous Antigens in Commensal Neisseria spp.: Preservation of Conformational Epitopes with Vaccine Potential. Infection and immunity, 72 (11), 6511-6518.
  • Reddin, K., Oliver, K., Borrow, R., Feavers, I. and Gorringe, A., 2004. Neisseria lactamica Protects against Experimental Meningococcal Infection. Infection and immunity, 70 (7), 3621-3626.
  • Reddin, K., Peeters, C., Lagerman, P. and Poolman, J., 2003. Preparation of Polysaccharide-Conjugate Vaccines. Methods in molecular medicine, 87, 153-174.
  • Reddin, K., West, D., Matheson, M., Heath, R., Funnell, S. and Gorringe, A., 2001. Recombinant Neisseria meningitidis Transferrin Binding Protein A Protects against Experimental Meningococcal Infection. Infection and immunity, 63 (3), 1562-1567.
  • Reddin, K., Lehmann, A., Gorringe, A. and Halstensen, A., 1999. Human Opsonins Induced during Meningococcal Disease Recognize Transferrin Binding Protein Complexes. Infection and immunity, 67 (12), 6526-6532.
  • Reddin, K., Eley, S., Mobsby, V., Jones, D., Farrar, G. and Williamson, E., 1998. Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis. Vaccine, 16 (8), 761-767.
  • Reddin, K., Wilks, K., Dunn, K., Farrant, J., Gorringe, A., Langford, P. and Kroll, S., 1998. Periplasmic Superoxide Dismutase in Meningococcal Pathogenicity. Infection and immunity, 66, 213-217.
  • Reddin, K., 1995. Studies on the immunogenicity of the Pla protein from Yersinia pestis. Contributions to microbiology and immunology, 13, 214-215.
  • Reddin, K., 1995. Large scale purification of F1 antigen of Yersinia pestis. Contributions to microbiology and immunology, 13, 329-330.

Chapters

  • Reddin, K. and MacDonald, G., 2016. Post Incident Follow-up. In: Selwood, C. and Wapling, A., eds. Health Emergency Planning and Response. CABI.
The data on this page was last updated at 04:15 on August 14, 2020.